Vivos Therapeutics, Inc. / Fundamentals

    Income statement

    Net revenue
    €12.35M
    Cost of goods sold
    €5.44M
    Gross profit
    €6.91M
    SG&A expenses
    €18.46M
    R&D expenses
    €85.80K
    EBITDA
    -€11.52M
    D&A
    €663.23K
    EBIT
    -€11.80M
    Interest expenses
    €0.00
    EBT
    -€12.29M
    Tax expenses
    -€1.23M
    Net income
    -€12.29M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€2.15M
    Changes in working capital
    €1.12M
    Operating cash flow
    -€12.37M
    Capex
    €622.05K
    Other investing cash flow
    -€592.02K
    Net investing cash flow
    -€5.48M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€4.90M
    Debt repayment
    €8.27M
    Other financing cash flow
    €2.87M
    Net financing cash flow
    €15.70M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€2.15M
    Cash at end of period
    €3.78M
    Free cash flow
    -€11.75M

    Balance sheet

    Cash and cash equivalents
    €3.78M
    Cash and short-term investments
    €3.78M
    Total receivables
    €1.40M
    Inventory
    €0.00
    Other current assets
    €596.31K
    Total current assets
    €5.77M
    Property, plant & equipment
    €7.18M
    Goodwill
    €7.25M
    Intangible assets
    €1.91M
    Long-term investments
    €0.00
    Other non-current assets
    €218.79K
    Total non-current assets
    €16.56M
    Total assets
    €22.34M
    Accounts payable
    €1.51M
    Short-term debt
    €743.03K
    Other current liabilities
    €2.85M
    Total current liabilities
    €5.51M
    Long-term debt
    €9.19M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €3.69M
    Total non-current liabilities
    €12.89M
    Total liabilities
    €18.40M
    Common stock
    €0.00
    Retained earnings
    -€97.01M
    Other equity
    €0.00
    Total equity
    €3.93M
    Total liabilities and shareholders' equity
    €22.34M

    Company information

    Market capitalization
    €16.48M
    Employees
    109
    Enterprise Value
    €12.13M

    Company ratios

    Gross margin
    55.9% Much better than peer group: -147.9%
    EBITDA margin
    -93.3% Much better than peer group: -37,224.0%
    EBIT margin
    -95.5% Much better than peer group: -37,357.5%
    EBT margin
    -99.5% Much better than peer group: -37,374.4%
    Net margin
    -99.5% Much better than peer group: -37,326.3%
    ROE
    -312.5% Much worse than peer group: -95.4%
    ROA
    -55.0% Much better than peer group: -16,192.6%
    Asset turnover
    55.3% Much better than peer group: 17.1%
    FCF margin
    -105.2% Much better than peer group: -27,931.3%
    FCF yield
    -78.8%
    Efficiency ratio
    193.3%
    Net sales per employee
    €113.30K
    Net income per employee
    -€112.72K

    Notifications